Dong Xu
Company: TScan Therapeutics
Job title: Associate Director
Seminars:
Chair’s Opening Remarks 7:30 am
day: Conference Day 1 Morning
Track Chair 11:15 am
day: Day 1 - Track A - Morning
Analytical Development to Assess T-Cell Therapy Product Potency: A Matrix Approach 12:00 pm
Understand the FDA draft guidance on cell therapy potency assurance Multiple mechanism of action-based assays for TCR T-cell therapies Matrix-based potency assessment and its implicationsRead more
day: Day 2 - Track A - Morning